nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinapril—SLC15A2—melanoma	0.854	1	CbGaD
Quinapril—ACE—umbilical vein—melanoma	0.00677	0.164	CbGeAlD
Quinapril—ACE—hindlimb—melanoma	0.00619	0.15	CbGeAlD
Quinapril—ACE—arm—melanoma	0.00591	0.143	CbGeAlD
Quinapril—ACE—appendage—melanoma	0.00531	0.129	CbGeAlD
Quinapril—ACE—endothelium—melanoma	0.00321	0.0778	CbGeAlD
Quinapril—ACE—blood vessel—melanoma	0.00296	0.0717	CbGeAlD
Quinapril—ACE—neck—melanoma	0.00212	0.0513	CbGeAlD
Quinapril—SLC15A1—mammalian vulva—melanoma	0.00174	0.0422	CbGeAlD
Quinapril—ACE—eye—melanoma	0.00157	0.0382	CbGeAlD
Quinapril—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.00144	0.379	CbGpPWpGaD
Quinapril—SLC15A2—retina—melanoma	0.00136	0.033	CbGeAlD
Quinapril—ACE—mammalian vulva—melanoma	0.00125	0.0303	CbGeAlD
Quinapril—Photosensitivity reaction—Vemurafenib—melanoma	0.00109	0.0116	CcSEcCtD
Quinapril—Viral infection—Temozolomide—melanoma	0.00108	0.0114	CcSEcCtD
Quinapril—Infestation—Vemurafenib—melanoma	0.00107	0.0113	CcSEcCtD
Quinapril—Infestation NOS—Vemurafenib—melanoma	0.00107	0.0113	CcSEcCtD
Quinapril—Perindopril—SLC15A2—melanoma	0.00101	0.139	CrCbGaD
Quinapril—Spirapril—SLC15A2—melanoma	0.000994	0.138	CrCbGaD
Quinapril—Moexipril—SLC15A2—melanoma	0.000953	0.132	CrCbGaD
Quinapril—Connective tissue disorder—Vemurafenib—melanoma	0.000942	0.00998	CcSEcCtD
Quinapril—Eye disorder—Vemurafenib—melanoma	0.000895	0.00949	CcSEcCtD
Quinapril—ACE—head—melanoma	0.000894	0.0217	CbGeAlD
Quinapril—Cardiac disorder—Vemurafenib—melanoma	0.000889	0.00942	CcSEcCtD
Quinapril—Cilazapril—SLC15A2—melanoma	0.000886	0.123	CrCbGaD
Quinapril—Angiopathy—Vemurafenib—melanoma	0.000869	0.00921	CcSEcCtD
Quinapril—Mediastinal disorder—Vemurafenib—melanoma	0.000864	0.00915	CcSEcCtD
Quinapril—Ramipril—SLC15A2—melanoma	0.000858	0.119	CrCbGaD
Quinapril—Trandolapril—SLC15A2—melanoma	0.000858	0.119	CrCbGaD
Quinapril—Cerebrovascular accident—Bleomycin—melanoma	0.000856	0.00907	CcSEcCtD
Quinapril—Alopecia—Vemurafenib—melanoma	0.000847	0.00897	CcSEcCtD
Quinapril—Back pain—Vemurafenib—melanoma	0.000807	0.00855	CcSEcCtD
Quinapril—SLC15A2—head—melanoma	0.000779	0.0189	CbGeAlD
Quinapril—Benazepril—SLC15A2—melanoma	0.000771	0.107	CrCbGaD
Quinapril—Dermatitis exfoliative—Temozolomide—melanoma	0.00075	0.00795	CcSEcCtD
Quinapril—Gastrointestinal haemorrhage—Carmustine—melanoma	0.000733	0.00776	CcSEcCtD
Quinapril—Cough—Vemurafenib—melanoma	0.000728	0.00771	CcSEcCtD
Quinapril—Liver function test abnormal—Dactinomycin—melanoma	0.000723	0.00766	CcSEcCtD
Quinapril—Arthralgia—Vemurafenib—melanoma	0.00071	0.00752	CcSEcCtD
Quinapril—Myalgia—Vemurafenib—melanoma	0.00071	0.00752	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000705	0.00747	CcSEcCtD
Quinapril—Anaphylactic shock—Vemurafenib—melanoma	0.000681	0.00721	CcSEcCtD
Quinapril—Infection—Vemurafenib—melanoma	0.000676	0.00717	CcSEcCtD
Quinapril—Liver function test abnormal—Carmustine—melanoma	0.000676	0.00717	CcSEcCtD
Quinapril—Nervous system disorder—Vemurafenib—melanoma	0.000668	0.00707	CcSEcCtD
Quinapril—Skin disorder—Vemurafenib—melanoma	0.000661	0.00701	CcSEcCtD
Quinapril—Breast disorder—Temozolomide—melanoma	0.00064	0.00678	CcSEcCtD
Quinapril—Acute coronary syndrome—Bleomycin—melanoma	0.000637	0.00675	CcSEcCtD
Quinapril—Myocardial infarction—Bleomycin—melanoma	0.000634	0.00672	CcSEcCtD
Quinapril—ACE—lymph node—melanoma	0.000626	0.0152	CbGeAlD
Quinapril—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00062	0.00657	CcSEcCtD
Quinapril—Sweating increased—Temozolomide—melanoma	0.000596	0.00631	CcSEcCtD
Quinapril—Gastrointestinal disorder—Vemurafenib—melanoma	0.000588	0.00623	CcSEcCtD
Quinapril—Fatigue—Vemurafenib—melanoma	0.000587	0.00622	CcSEcCtD
Quinapril—Constipation—Vemurafenib—melanoma	0.000582	0.00617	CcSEcCtD
Quinapril—Erectile dysfunction—Temozolomide—melanoma	0.000563	0.00597	CcSEcCtD
Quinapril—Depression—Carmustine—melanoma	0.000563	0.00596	CcSEcCtD
Quinapril—Agranulocytosis—Dactinomycin—melanoma	0.000563	0.00596	CcSEcCtD
Quinapril—Photosensitivity reaction—Temozolomide—melanoma	0.000558	0.00592	CcSEcCtD
Quinapril—Renal failure—Carmustine—melanoma	0.000555	0.00588	CcSEcCtD
Quinapril—Urinary tract infection—Carmustine—melanoma	0.000549	0.00581	CcSEcCtD
Quinapril—SLC15A2—lymph node—melanoma	0.000546	0.0132	CbGeAlD
Quinapril—Infestation NOS—Temozolomide—melanoma	0.000546	0.00578	CcSEcCtD
Quinapril—Infestation—Temozolomide—melanoma	0.000546	0.00578	CcSEcCtD
Quinapril—Depression—Temozolomide—melanoma	0.000544	0.00576	CcSEcCtD
Quinapril—Hepatitis—Dactinomycin—melanoma	0.000541	0.00574	CcSEcCtD
Quinapril—Pharyngitis—Dactinomycin—melanoma	0.000537	0.00569	CcSEcCtD
Quinapril—Urinary tract infection—Temozolomide—melanoma	0.00053	0.00562	CcSEcCtD
Quinapril—Hepatobiliary disease—Temozolomide—melanoma	0.000516	0.00547	CcSEcCtD
Quinapril—Alopecia—Bleomycin—melanoma	0.000513	0.00544	CcSEcCtD
Quinapril—Connective tissue disorder—Carmustine—melanoma	0.000498	0.00528	CcSEcCtD
Quinapril—Hepatitis—Temozolomide—melanoma	0.00049	0.00519	CcSEcCtD
Quinapril—Asthenia—Vemurafenib—melanoma	0.000488	0.00518	CcSEcCtD
Quinapril—Pharyngitis—Temozolomide—melanoma	0.000486	0.00515	CcSEcCtD
Quinapril—Urinary tract disorder—Temozolomide—melanoma	0.000484	0.00512	CcSEcCtD
Quinapril—Pruritus—Vemurafenib—melanoma	0.000482	0.0051	CcSEcCtD
Quinapril—Connective tissue disorder—Temozolomide—melanoma	0.000481	0.0051	CcSEcCtD
Quinapril—Urethral disorder—Temozolomide—melanoma	0.00048	0.00509	CcSEcCtD
Quinapril—Alopecia—Dactinomycin—melanoma	0.000478	0.00507	CcSEcCtD
Quinapril—Eye disorder—Carmustine—melanoma	0.000474	0.00502	CcSEcCtD
Quinapril—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000471	0.00499	CcSEcCtD
Quinapril—Ill-defined disorder—Bleomycin—melanoma	0.000469	0.00497	CcSEcCtD
Quinapril—Diarrhoea—Vemurafenib—melanoma	0.000466	0.00494	CcSEcCtD
Quinapril—Eye disorder—Temozolomide—melanoma	0.000458	0.00485	CcSEcCtD
Quinapril—Malaise—Bleomycin—melanoma	0.000456	0.00483	CcSEcCtD
Quinapril—Cardiac disorder—Temozolomide—melanoma	0.000454	0.00482	CcSEcCtD
Quinapril—Arrhythmia—Carmustine—melanoma	0.000453	0.0048	CcSEcCtD
Quinapril—Dizziness—Vemurafenib—melanoma	0.00045	0.00477	CcSEcCtD
Quinapril—Alopecia—Carmustine—melanoma	0.000448	0.00474	CcSEcCtD
Quinapril—Angiopathy—Temozolomide—melanoma	0.000444	0.00471	CcSEcCtD
Quinapril—Mental disorder—Carmustine—melanoma	0.000444	0.0047	CcSEcCtD
Quinapril—Immune system disorder—Temozolomide—melanoma	0.000442	0.00469	CcSEcCtD
Quinapril—Mediastinal disorder—Temozolomide—melanoma	0.000441	0.00468	CcSEcCtD
Quinapril—Cough—Bleomycin—melanoma	0.000441	0.00467	CcSEcCtD
Quinapril—Ill-defined disorder—Dactinomycin—melanoma	0.000437	0.00463	CcSEcCtD
Quinapril—Liver function test abnormal—Docetaxel—melanoma	0.000435	0.00461	CcSEcCtD
Quinapril—Vomiting—Vemurafenib—melanoma	0.000433	0.00459	CcSEcCtD
Quinapril—Alopecia—Temozolomide—melanoma	0.000433	0.00459	CcSEcCtD
Quinapril—Chest pain—Bleomycin—melanoma	0.00043	0.00456	CcSEcCtD
Quinapril—Myalgia—Bleomycin—melanoma	0.00043	0.00456	CcSEcCtD
Quinapril—Orthostatic hypotension—Docetaxel—melanoma	0.00043	0.00456	CcSEcCtD
Quinapril—Rash—Vemurafenib—melanoma	0.000429	0.00455	CcSEcCtD
Quinapril—Mental disorder—Temozolomide—melanoma	0.000429	0.00455	CcSEcCtD
Quinapril—Dermatitis—Vemurafenib—melanoma	0.000429	0.00454	CcSEcCtD
Quinapril—Back pain—Carmustine—melanoma	0.000427	0.00452	CcSEcCtD
Quinapril—Headache—Vemurafenib—melanoma	0.000426	0.00452	CcSEcCtD
Quinapril—Breast disorder—Docetaxel—melanoma	0.000425	0.00451	CcSEcCtD
Quinapril—Discomfort—Bleomycin—melanoma	0.000425	0.0045	CcSEcCtD
Quinapril—Malaise—Dactinomycin—melanoma	0.000425	0.0045	CcSEcCtD
Quinapril—Anaphylactic shock—Bleomycin—melanoma	0.000412	0.00437	CcSEcCtD
Quinapril—Oedema—Bleomycin—melanoma	0.000412	0.00437	CcSEcCtD
Quinapril—Back pain—Temozolomide—melanoma	0.000412	0.00437	CcSEcCtD
Quinapril—Infection—Bleomycin—melanoma	0.00041	0.00434	CcSEcCtD
Quinapril—Nausea—Vemurafenib—melanoma	0.000404	0.00428	CcSEcCtD
Quinapril—Thrombocytopenia—Bleomycin—melanoma	0.000404	0.00428	CcSEcCtD
Quinapril—Myalgia—Dactinomycin—melanoma	0.000401	0.00425	CcSEcCtD
Quinapril—Discomfort—Dactinomycin—melanoma	0.000396	0.0042	CcSEcCtD
Quinapril—Angina pectoris—Docetaxel—melanoma	0.000396	0.0042	CcSEcCtD
Quinapril—Ill-defined disorder—Temozolomide—melanoma	0.000396	0.00419	CcSEcCtD
Quinapril—Angioedema—Temozolomide—melanoma	0.00039	0.00413	CcSEcCtD
Quinapril—Oedema—Dactinomycin—melanoma	0.000385	0.00408	CcSEcCtD
Quinapril—Malaise—Temozolomide—melanoma	0.000384	0.00407	CcSEcCtD
Quinapril—Vertigo—Temozolomide—melanoma	0.000383	0.00406	CcSEcCtD
Quinapril—Infection—Dactinomycin—melanoma	0.000382	0.00405	CcSEcCtD
Quinapril—Palpitations—Temozolomide—melanoma	0.000377	0.00399	CcSEcCtD
Quinapril—Thrombocytopenia—Dactinomycin—melanoma	0.000377	0.00399	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Bleomycin—melanoma	0.000376	0.00398	CcSEcCtD
Quinapril—Chest pain—Carmustine—melanoma	0.000376	0.00398	CcSEcCtD
Quinapril—Myalgia—Carmustine—melanoma	0.000376	0.00398	CcSEcCtD
Quinapril—Cough—Temozolomide—melanoma	0.000372	0.00394	CcSEcCtD
Quinapril—Paraesthesia—Bleomycin—melanoma	0.00037	0.00392	CcSEcCtD
Quinapril—Dyspnoea—Bleomycin—melanoma	0.000368	0.0039	CcSEcCtD
Quinapril—Arthralgia—Temozolomide—melanoma	0.000363	0.00385	CcSEcCtD
Quinapril—Myalgia—Temozolomide—melanoma	0.000363	0.00385	CcSEcCtD
Quinapril—Infestation NOS—Docetaxel—melanoma	0.000363	0.00384	CcSEcCtD
Quinapril—Infestation—Docetaxel—melanoma	0.000363	0.00384	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00036	0.00382	CcSEcCtD
Quinapril—Oedema—Carmustine—melanoma	0.00036	0.00381	CcSEcCtD
Quinapril—Discomfort—Temozolomide—melanoma	0.000359	0.0038	CcSEcCtD
Quinapril—Infection—Carmustine—melanoma	0.000358	0.00379	CcSEcCtD
Quinapril—Acute coronary syndrome—Docetaxel—melanoma	0.000358	0.00379	CcSEcCtD
Quinapril—Renal failure—Docetaxel—melanoma	0.000357	0.00378	CcSEcCtD
Quinapril—Myocardial infarction—Docetaxel—melanoma	0.000356	0.00377	CcSEcCtD
Quinapril—Dry mouth—Temozolomide—melanoma	0.000355	0.00376	CcSEcCtD
Quinapril—Thrombocytopenia—Carmustine—melanoma	0.000352	0.00374	CcSEcCtD
Quinapril—Tachycardia—Carmustine—melanoma	0.000351	0.00372	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00035	0.00371	CcSEcCtD
Quinapril—Anaphylactic shock—Temozolomide—melanoma	0.000348	0.00369	CcSEcCtD
Quinapril—Oedema—Temozolomide—melanoma	0.000348	0.00369	CcSEcCtD
Quinapril—Infection—Temozolomide—melanoma	0.000346	0.00366	CcSEcCtD
Quinapril—Hepatobiliary disease—Docetaxel—melanoma	0.000343	0.00364	CcSEcCtD
Quinapril—Nervous system disorder—Temozolomide—melanoma	0.000341	0.00362	CcSEcCtD
Quinapril—Thrombocytopenia—Temozolomide—melanoma	0.000341	0.00361	CcSEcCtD
Quinapril—Feeling abnormal—Bleomycin—melanoma	0.00034	0.0036	CcSEcCtD
Quinapril—Agranulocytosis—Docetaxel—melanoma	0.000339	0.00359	CcSEcCtD
Quinapril—Skin disorder—Temozolomide—melanoma	0.000338	0.00358	CcSEcCtD
Quinapril—Hyperhidrosis—Temozolomide—melanoma	0.000336	0.00356	CcSEcCtD
Quinapril—Fatigue—Dactinomycin—melanoma	0.000332	0.00351	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Carmustine—melanoma	0.000328	0.00348	CcSEcCtD
Quinapril—Hepatitis—Docetaxel—melanoma	0.000326	0.00345	CcSEcCtD
Quinapril—Insomnia—Carmustine—melanoma	0.000326	0.00345	CcSEcCtD
Quinapril—Paraesthesia—Carmustine—melanoma	0.000323	0.00343	CcSEcCtD
Quinapril—Pharyngitis—Docetaxel—melanoma	0.000323	0.00342	CcSEcCtD
Quinapril—Urinary tract disorder—Docetaxel—melanoma	0.000322	0.00341	CcSEcCtD
Quinapril—Dyspnoea—Carmustine—melanoma	0.000321	0.0034	CcSEcCtD
Quinapril—Somnolence—Carmustine—melanoma	0.00032	0.00339	CcSEcCtD
Quinapril—Connective tissue disorder—Docetaxel—melanoma	0.00032	0.00339	CcSEcCtD
Quinapril—Urethral disorder—Docetaxel—melanoma	0.000319	0.00338	CcSEcCtD
Quinapril—Feeling abnormal—Dactinomycin—melanoma	0.000317	0.00336	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Temozolomide—melanoma	0.000317	0.00336	CcSEcCtD
Quinapril—Insomnia—Temozolomide—melanoma	0.000315	0.00333	CcSEcCtD
Quinapril—Gastrointestinal pain—Dactinomycin—melanoma	0.000315	0.00333	CcSEcCtD
Quinapril—Paraesthesia—Temozolomide—melanoma	0.000312	0.00331	CcSEcCtD
Quinapril—Gastrointestinal disorder—Carmustine—melanoma	0.000311	0.00329	CcSEcCtD
Quinapril—Dyspnoea—Temozolomide—melanoma	0.00031	0.00329	CcSEcCtD
Quinapril—Somnolence—Temozolomide—melanoma	0.000309	0.00328	CcSEcCtD
Quinapril—Constipation—Carmustine—melanoma	0.000308	0.00326	CcSEcCtD
Quinapril—Dyspepsia—Temozolomide—melanoma	0.000306	0.00325	CcSEcCtD
Quinapril—Eye disorder—Docetaxel—melanoma	0.000304	0.00322	CcSEcCtD
Quinapril—Abdominal pain—Dactinomycin—melanoma	0.000304	0.00322	CcSEcCtD
Quinapril—Cardiac disorder—Docetaxel—melanoma	0.000302	0.0032	CcSEcCtD
Quinapril—Gastrointestinal disorder—Temozolomide—melanoma	0.0003	0.00318	CcSEcCtD
Quinapril—Fatigue—Temozolomide—melanoma	0.0003	0.00318	CcSEcCtD
Quinapril—Constipation—Temozolomide—melanoma	0.000298	0.00315	CcSEcCtD
Quinapril—Feeling abnormal—Carmustine—melanoma	0.000297	0.00314	CcSEcCtD
Quinapril—Asthenia—Bleomycin—melanoma	0.000296	0.00314	CcSEcCtD
Quinapril—Angiopathy—Docetaxel—melanoma	0.000295	0.00313	CcSEcCtD
Quinapril—Gastrointestinal pain—Carmustine—melanoma	0.000294	0.00312	CcSEcCtD
Quinapril—Immune system disorder—Docetaxel—melanoma	0.000294	0.00312	CcSEcCtD
Quinapril—Mediastinal disorder—Docetaxel—melanoma	0.000293	0.00311	CcSEcCtD
Quinapril—Pruritus—Bleomycin—melanoma	0.000292	0.00309	CcSEcCtD
Quinapril—Arrhythmia—Docetaxel—melanoma	0.000291	0.00308	CcSEcCtD
Quinapril—Alopecia—Docetaxel—melanoma	0.000288	0.00305	CcSEcCtD
Quinapril—Feeling abnormal—Temozolomide—melanoma	0.000287	0.00304	CcSEcCtD
Quinapril—Mental disorder—Docetaxel—melanoma	0.000285	0.00302	CcSEcCtD
Quinapril—Abdominal pain—Carmustine—melanoma	0.000285	0.00302	CcSEcCtD
Quinapril—Gastrointestinal pain—Temozolomide—melanoma	0.000284	0.00301	CcSEcCtD
Quinapril—Asthenia—Dactinomycin—melanoma	0.000276	0.00292	CcSEcCtD
Quinapril—Abdominal pain—Temozolomide—melanoma	0.000275	0.00291	CcSEcCtD
Quinapril—Back pain—Docetaxel—melanoma	0.000274	0.00291	CcSEcCtD
Quinapril—Diarrhoea—Dactinomycin—melanoma	0.000263	0.00279	CcSEcCtD
Quinapril—Vomiting—Bleomycin—melanoma	0.000262	0.00278	CcSEcCtD
Quinapril—Rash—Bleomycin—melanoma	0.00026	0.00276	CcSEcCtD
Quinapril—Dermatitis—Bleomycin—melanoma	0.00026	0.00275	CcSEcCtD
Quinapril—Asthenia—Carmustine—melanoma	0.000258	0.00274	CcSEcCtD
Quinapril—Syncope—Docetaxel—melanoma	0.000254	0.00269	CcSEcCtD
Quinapril—Palpitations—Docetaxel—melanoma	0.000251	0.00265	CcSEcCtD
Quinapril—Asthenia—Temozolomide—melanoma	0.00025	0.00264	CcSEcCtD
Quinapril—Loss of consciousness—Docetaxel—melanoma	0.000249	0.00264	CcSEcCtD
Quinapril—Cough—Docetaxel—melanoma	0.000247	0.00262	CcSEcCtD
Quinapril—Diarrhoea—Carmustine—melanoma	0.000246	0.00261	CcSEcCtD
Quinapril—Pruritus—Temozolomide—melanoma	0.000246	0.00261	CcSEcCtD
Quinapril—Nausea—Bleomycin—melanoma	0.000245	0.0026	CcSEcCtD
Quinapril—Vomiting—Dactinomycin—melanoma	0.000245	0.00259	CcSEcCtD
Quinapril—Rash—Dactinomycin—melanoma	0.000243	0.00257	CcSEcCtD
Quinapril—Chest pain—Docetaxel—melanoma	0.000241	0.00256	CcSEcCtD
Quinapril—Arthralgia—Docetaxel—melanoma	0.000241	0.00256	CcSEcCtD
Quinapril—Myalgia—Docetaxel—melanoma	0.000241	0.00256	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00024	0.00254	CcSEcCtD
Quinapril—Dizziness—Carmustine—melanoma	0.000238	0.00252	CcSEcCtD
Quinapril—Diarrhoea—Temozolomide—melanoma	0.000238	0.00252	CcSEcCtD
Quinapril—Dry mouth—Docetaxel—melanoma	0.000236	0.0025	CcSEcCtD
Quinapril—Anaphylactic shock—Docetaxel—melanoma	0.000231	0.00245	CcSEcCtD
Quinapril—Oedema—Docetaxel—melanoma	0.000231	0.00245	CcSEcCtD
Quinapril—Dizziness—Temozolomide—melanoma	0.00023	0.00244	CcSEcCtD
Quinapril—Infection—Docetaxel—melanoma	0.00023	0.00244	CcSEcCtD
Quinapril—Vomiting—Carmustine—melanoma	0.000229	0.00243	CcSEcCtD
Quinapril—Nausea—Dactinomycin—melanoma	0.000228	0.00242	CcSEcCtD
Quinapril—Shock—Docetaxel—melanoma	0.000228	0.00241	CcSEcCtD
Quinapril—Rash—Carmustine—melanoma	0.000227	0.00241	CcSEcCtD
Quinapril—Nervous system disorder—Docetaxel—melanoma	0.000227	0.0024	CcSEcCtD
Quinapril—Dermatitis—Carmustine—melanoma	0.000227	0.0024	CcSEcCtD
Quinapril—Thrombocytopenia—Docetaxel—melanoma	0.000227	0.0024	CcSEcCtD
Quinapril—Tachycardia—Docetaxel—melanoma	0.000226	0.00239	CcSEcCtD
Quinapril—Headache—Carmustine—melanoma	0.000226	0.00239	CcSEcCtD
Quinapril—Skin disorder—Docetaxel—melanoma	0.000225	0.00238	CcSEcCtD
Quinapril—Vomiting—Temozolomide—melanoma	0.000221	0.00234	CcSEcCtD
Quinapril—Rash—Temozolomide—melanoma	0.000219	0.00232	CcSEcCtD
Quinapril—Dermatitis—Temozolomide—melanoma	0.000219	0.00232	CcSEcCtD
Quinapril—Headache—Temozolomide—melanoma	0.000218	0.00231	CcSEcCtD
Quinapril—Nausea—Carmustine—melanoma	0.000214	0.00227	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Docetaxel—melanoma	0.000211	0.00223	CcSEcCtD
Quinapril—Insomnia—Docetaxel—melanoma	0.000209	0.00222	CcSEcCtD
Quinapril—Paraesthesia—Docetaxel—melanoma	0.000208	0.0022	CcSEcCtD
Quinapril—Nausea—Temozolomide—melanoma	0.000207	0.00219	CcSEcCtD
Quinapril—Perindopril—ABCB1—melanoma	0.000206	0.0286	CrCbGaD
Quinapril—Dyspnoea—Docetaxel—melanoma	0.000206	0.00219	CcSEcCtD
Quinapril—Somnolence—Docetaxel—melanoma	0.000206	0.00218	CcSEcCtD
Quinapril—Dyspepsia—Docetaxel—melanoma	0.000204	0.00216	CcSEcCtD
Quinapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000201	0.053	CbGpPWpGaD
Quinapril—Gastrointestinal disorder—Docetaxel—melanoma	0.0002	0.00212	CcSEcCtD
Quinapril—Fatigue—Docetaxel—melanoma	0.000199	0.00211	CcSEcCtD
Quinapril—Constipation—Docetaxel—melanoma	0.000198	0.0021	CcSEcCtD
Quinapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.000194	0.0511	CbGpPWpGaD
Quinapril—Feeling abnormal—Docetaxel—melanoma	0.000191	0.00202	CcSEcCtD
Quinapril—Gastrointestinal pain—Docetaxel—melanoma	0.000189	0.002	CcSEcCtD
Quinapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.000186	0.0492	CbGpPWpGaD
Quinapril—Abdominal pain—Docetaxel—melanoma	0.000183	0.00194	CcSEcCtD
Quinapril—Lisinopril—ABCB1—melanoma	0.000182	0.0252	CrCbGaD
Quinapril—Cilazapril—ABCB1—melanoma	0.000182	0.0252	CrCbGaD
Quinapril—Asthenia—Docetaxel—melanoma	0.000166	0.00176	CcSEcCtD
Quinapril—Pruritus—Docetaxel—melanoma	0.000164	0.00173	CcSEcCtD
Quinapril—Diarrhoea—Docetaxel—melanoma	0.000158	0.00168	CcSEcCtD
Quinapril—Dizziness—Docetaxel—melanoma	0.000153	0.00162	CcSEcCtD
Quinapril—Vomiting—Docetaxel—melanoma	0.000147	0.00156	CcSEcCtD
Quinapril—Rash—Docetaxel—melanoma	0.000146	0.00155	CcSEcCtD
Quinapril—Dermatitis—Docetaxel—melanoma	0.000146	0.00154	CcSEcCtD
Quinapril—Headache—Docetaxel—melanoma	0.000145	0.00154	CcSEcCtD
Quinapril—Nausea—Docetaxel—melanoma	0.000137	0.00146	CcSEcCtD
Quinapril—Enalapril—ABCB1—melanoma	0.000134	0.0185	CrCbGaD
Quinapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000118	0.0312	CbGpPWpGaD
Quinapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.000114	0.0301	CbGpPWpGaD
Quinapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.00011	0.029	CbGpPWpGaD
Quinapril—Propafenone—ABCB1—melanoma	0.000107	0.0148	CrCbGaD
Quinapril—ACE—Peptide hormone metabolism—PAX6—melanoma	9.51e-05	0.0251	CbGpPWpGaD
Quinapril—Fentanyl—ABCB1—melanoma	8.79e-05	0.0122	CrCbGaD
Quinapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	8.34e-05	0.022	CbGpPWpGaD
Quinapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	7.74e-05	0.0204	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—PIGU—melanoma	5.86e-05	0.0155	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—ADAMTS20—melanoma	5.86e-05	0.0155	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—ARL2—melanoma	5.36e-05	0.0141	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—ABCB5—melanoma	5.31e-05	0.014	CbGpPWpGaD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—SLC17A5—melanoma	5.28e-05	0.0139	CbGpPWpGaD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	5.1e-05	0.0134	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	4.93e-05	0.013	CbGpPWpGaD
Quinapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	4.91e-05	0.013	CbGpPWpGaD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	4.9e-05	0.0129	CbGpPWpGaD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	4.8e-05	0.0127	CbGpPWpGaD
Quinapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	4.56e-05	0.012	CbGpPWpGaD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	4.45e-05	0.0117	CbGpPWpGaD
Quinapril—ACE—Peptide hormone metabolism—IGF1—melanoma	4.33e-05	0.0114	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—SLC17A5—melanoma	3.91e-05	0.0103	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—ADAMTS13—melanoma	3.78e-05	0.00996	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	3.68e-05	0.00971	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	3.42e-05	0.00901	CbGpPWpGaD
Quinapril—ACE—Peptide hormone metabolism—CTNNB1—melanoma	3.21e-05	0.00847	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—RPS3—melanoma	2.82e-05	0.00743	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	2.69e-05	0.00708	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	2.59e-05	0.00683	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	2.49e-05	0.00658	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	2.44e-05	0.00643	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	2.26e-05	0.00597	CbGpPWpGaD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	2.19e-05	0.00579	CbGpPWpGaD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	2.04e-05	0.00537	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—PAX6—melanoma	1.8e-05	0.00474	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—HSPA5—melanoma	1.73e-05	0.00455	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	1.12e-05	0.00294	CbGpPWpGaD
Quinapril—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	1.05e-05	0.00276	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.03e-05	0.00273	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—MMP1—melanoma	1.02e-05	0.0027	CbGpPWpGaD
Quinapril—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	9.72e-06	0.00256	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	8.5e-06	0.00224	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—IGF1—melanoma	8.17e-06	0.00216	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—MMP2—melanoma	7.91e-06	0.00209	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	7.89e-06	0.00208	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—CXCL8—melanoma	6.57e-06	0.00173	CbGpPWpGaD
Quinapril—ACE—Metabolism of proteins—CTNNB1—melanoma	6.06e-06	0.0016	CbGpPWpGaD
Quinapril—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	5.32e-06	0.0014	CbGpPWpGaD
Quinapril—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	4.94e-06	0.0013	CbGpPWpGaD
